product summary
company name :
BioVision
product type :
antibody
product name :
mCherry Antibody
catalog :
5993-100
conjugate :
nonconjugated
reactivity :
mouse
application :
western blot, immunocytochemistry, western blot knockout validation
more info or order :
BioVision product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot knockout validation; mouse; 1:200; fig 5b
Huang L, Pike D, Sleat D, Nanda V, Lobel P. Potential pitfalls and solutions for use of fluorescent fusion proteins to study the lysosome. PLoS ONE. 2014;9:e88893 pubmed publisher
Puschmann A, Fiesel F, Caulfield T, Hudec R, Ando M, Truban D, et al. Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism. Brain. 2017;140:98-117 pubmed publisher
Hobbs R, DePianto D, Jacob J, Han M, Chung B, Batazzi A, et al. Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes. Nat Genet. 2015;47:933-8 pubmed publisher
company information
BioVision
980 Linda Vista Avenue
Mountain View, California 94043
support@biovision.com
http://www.biovision.com
1-650-428-0236
headquarters: USA
BioVision, Inc., a privately held company headquartered in the beautiful San Francisco Bay area, specializes in developing and manufacturing research products for molecular and cell biologists. BioVision offers a wide variety of products including reagents, bioassay kits, antibodies, recombinant proteins, and other research tools for studying apoptosis, cell signaling pathways, cell proliferation, metabolism, cellular stress, cell damage and repair, cholesterol and obesity, Protein A/G/L, multi-color fluorescence proteins and gene regulation, etc. BioVision’s products are currently being sold in more than 60 countries worldwide.